Regulatory

Number of shares and votes in Ascelia Pharma AB

2021-04-30
Download

During April 2021, the number of common shares increased by 5,000,000 as a result of the completed directed new share issue. The number of C-shares also increased in April by 397,641 following a directed share issue and repurchase of these shares (the C-shares are held by Ascelia Pharma). The issue of C-shares is linked to the company's share saving program (LTI 2020), which was resolved by the Annual General Meeting on May 6, 2020.

As of April 30, 2021, the number of shares amounts to 34,576,448, of which 33,668,262 are common shares with one vote per share and 908,186 are C-shares with one tenth of a vote each. The total number of votes in the company amounts to 33,759,080.6. 

2021-05-12

Quarterly Report Q1 2021: US office opened in preparation of launch

Ascelia Pharma AB (publ) (ticker: ACE) today published its quarterly financial report for Q1 2021 (January – March 2021), which is now available on the company’s website: https://www.ascelia.com/ir-media/reports-presentations
2021-05-05

Bulletin from the Annual General Meeting in Ascelia Pharma AB on 5 May 2021

Today, on 5 May 2021, the annual general meeting was held in Ascelia Pharma AB. In light of the ongoing Covid-19 pandemic and in order to reduce the risk of infection spreading, the annual general meeting was held only by advance voting (postal vote) in accordance with temporary legislation. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority of votes.
2021-04-30

Number of shares and votes in Ascelia Pharma AB